A Decade of Innovation, Hope and Healing: Mercy Research Marks Milestone
ST. LOUIS, Nov. 17, 2026
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
A Decade of Innovation, Hope and Healing: Mercy Research Marks Milestone
PR Newswire
ST. LOUIS, Nov. 17, 2026
Key points:
- Mercy Research is celebrating 10 years of advancing care through research and expanding patient access to clinical research.
- Mercy Research offers more than 300 clinical trials across multiple specialties.
- Clinical trial opportunities are available in communities across Mercy’s multi-state footprint, allowing patients to participate in care closer to home.
ST. LOUIS, Nov. 17, 2026 /PRNewswire/ — With the release of its annual report, Mercy Research marks 10 years of bringing clinical trial opportunities to Mercy patients. Over the past decade, Mercy Research has grown into a nationally recognized program offering more than 300 clinical trials in specialties including cancer, cardiovascular disease, neuroscience and infectious disease.
For Mercy patients, research represents more than future discoveries. Clinical trials can provide eligible participants with early access to promising therapies, advanced diagnostics and innovative treatment approaches years before they become widely available.
Mercy’s community-based approach opens research opportunities across its service area, helping reduce travel and financial barriers that have historically limited patient access to clinical trial participation. Three years after a pancreatic cancer diagnosis and various treatments, Deborah Cottle gained access to a then-investigational new drug through the FDA’s expanded access program (EAP) offered by Mercy Oncology and Mercy Research. Cottle was able to stay in her home community for care rather than driving hours to a larger academic site, giving her more time with her family.
“The structure we’ve established with researchers working at a community level highlights Mercy’s care model of accessibility and keeping patients close to home,” said JoAnne Levy, Mercy Research vice president. “We want to bring clinical trials to our patients, enabling all who qualify for a clinical trial to have access without the additional cost of travel.”
Over the past 10 years, Mercy researchers and patients have contributed to advancements in cancer early detection, heart failure treatment, proton beam therapy and sepsis identification, helping bring new discoveries from the laboratory to the bedside.
Looking ahead, Mercy Research plans to continue expanding access to clinical trials, precision medicine initiatives, AI-enabled research and innovative treatment options that help patients receive advanced care close to home.
Mercy, one of the 15 largest U.S. health systems and named the top large system in the U.S. for excellent patient experience by NRC Health, serves millions annually with nationally recognized care and one of the nation’s largest and highest performing Accountable Care Organizations in quality and cost. Mercy is a highly integrated, multi-state healthcare system including 55 acute care and specialty (heart, children’s, orthopedic and rehab) hospitals, convenient and urgent care locations, imaging centers and pharmacies. Mercy has over 1,000 physician practice locations and outpatient facilities, more than 6,000 physicians and advanced practitioners and more than 50,000 caregivers serving patients and families across Arkansas, Illinois, Kansas, Missouri and Oklahoma. Mercy also has clinics, outpatient services and outreach ministries in Arkansas, Louisiana, Mississippi and Texas. In fiscal year 2025 alone, Mercy provided more than half a billion dollars of free care and other community benefits, including traditional charity care and unreimbursed Medicaid.
View original content to download multimedia:https://www.prnewswire.com/news-releases/a-decade-of-innovation-hope-and-healing-mercy-research-marks-milestone-302941680.html
SOURCE Mercy



